A facility for safe research on dangerous pathogens
Official title: BSL-3 Practices Core
Funded at University of Tennessee Health Sci Ctr · NIH-10910182 · Data updated 2026-11-12
The University of Tennessee Health Science Center is working on making sure that research with dangerous germs is done safely, so scientists can better understand and treat infections that affect people like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tennessee Health Sci Ctr NIH-funded |
| Lab location | 1 site (Memphis, United States) |
| Project start | August 18, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $366,121 |
| NIH project number | 5UC7AI180313-02 |
| Project ID | NIH-10910182 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include researchers and healthcare professionals working with infectious diseases that require BSL-3 containment.
✕Less likely to help
Patients who are not involved in research or do not have conditions related to infectious diseases may not receive direct benefits from this research.
What this research studies
The University of Tennessee Health Science Center's Regional Biocontainment Laboratory (RBL) focuses on maintaining a safe environment for research involving potentially harmful bacteria, viruses, and fungi. This facility is equipped with specialized management, engineering controls, and trained staff to ensure compliance with biosafety standards. The BSL-3 Practices Core aims to streamline operations, enhance communication among safety teams, and ensure that all research conducted meets rigorous safety and security protocols. By facilitating research that requires high-level containment, the RBL supports critical studies that could lead to advancements in understanding and treating infectious diseases.
Why it matters
Potential benefit: If successful, this research could enhance the safety and efficiency of studies on infectious diseases, potentially leading to new treatments and preventive measures.
How similar studies have gone: Other research facilities with similar biosafety practices have shown success in advancing our understanding of infectious diseases, indicating that this approach is effective.
Where this research is happening
-
University of Tennessee Health Sci Ctr
Memphis, United States Active
Researchers
- Principal investigator: Kong, Ying — University of Tennessee Health Sci Ctr
- Study coordinator: Kong, Ying
Related research
Other NIH-funded projects on the same topics.
-
EP2 blockers to protect the brain after a stroke
Aims to test brain-permeable EP2 antagonists to reduce damage after ischemic stroke and improve recovery.
-
HIV drugs may also stop a dangerous fungus from growing
A cancer/antifungal researcher is exploring whether HIV medicines can help treat cryptococcal infections in people with HIV/AIDS.
-
Profiling immune cells to find early inflammation clues in kids with obesity and insulin resistance
This project looks at how immune cells in children with obesity may show early inflammatory changes linked to insulin resistance.
-
Targeted inhibitors to block a key enzyme and fight metastatic triple-negative breast cancer
A new drug candidate aimed at a specific enzyme in cancer cells is being developed to stop the spread of metastatic triple-negative breast cancer.
-
New fungal partner targets to curb Aspergillus infection in vulnerable patients
A NIH-funded project is exploring how the fungus Aspergillus fumigatus grows and causes serious infections in people with weakened immune systems, with the aim of finding new ways to stop it.
-
Epigenetic control of aging heart function
A scientist at a university is studying how aging changes heart function and whether a specific gene, KDM6A, influences this process to uncover ways to prevent or treat aging-related heart problems.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.